Therapeutics News

ATLANTA – The most important first step in ocular pain management is determining why it exists, Jessica Steen, OD, said here at SECO.

ATLANTA – Through the new Natacyn Next Day campaign, Eyevance Pharmaceuticals will cover overnight shipping charges to ensure patients in need of the prescription ocular antifungal agent can receive it the next day.

ATLANTA — Alcon presented the latest innovations to the company’s products at this year’s SECO meeting, including Precision1 for Astigmatism, a new entry to the Systane eye drop line and news of an upcoming monthly reusable contact lens.

This year's SECO meeting will be a mix of virtual presentations and live sessions that will take place in Atlanta, April 28 to May 2.

Most adults with thyroid eye disease receiving an infusion of teprotumumab every 3 weeks for a 24-week period had a reduction of at least 2 mm in proptosis, with a long-term response observed in 67% of participants, according to study data.

MediPrint Ophthalmic announced that the SIGHT-1 clinical trial found a favorable safety and tolerability profile and demonstrated single dose efficacy of the LLT-BMT1 drug-eluting contact lens to treat mild to moderate glaucoma or ocular hypertension.

The Japanese Ministry of Health, Labour and Welfare approved Johnson & Johnson Vision’s Acuvue Theravision with Ketotifen, a drug-releasing combination contact lens designed for both vision correction and allergic eye itch relief.

On March 17, Mississippi Governor Tate Reeves approved a bill that included amendments to expand the scope of practice for optometrists in the state, including the ability to prescribe certain medications and perform specific procedures.

Bausch + Lomb’s Alaway, an over-the-counter eye drop, is set to launch in the U.S., the company announced in a press release.

The Mississippi Senate passed a House bill that expanded the scope of practice for optometrists in the state, including the ability to prescribe certain medications and perform specific procedures.